• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy.内毒素休克的治疗——血管升压药与血管扩张剂治疗的困境
Calif Med. 1962 Feb;96(2):86-8.
2
Studies on experimental shock: production of ischemic necrosis of the skin by an intradermal injection of endotoxin or vasopressor amine.实验性休克研究:通过皮内注射内毒素或血管升压胺产生皮肤缺血性坏死。
Am J Pathol. 1960 Nov;37(5):551-67.
3
Vasopressor and vasodilator drugs in the treatment of shock.血管加压药和血管扩张药在休克治疗中的应用。
Mod Treat. 1967 Mar;4(2):243-55.
4
Effects of vasopressin, norepinephrine, and L-arginine on intestinal microcirculation in endotoxemia.血管加压素、去甲肾上腺素和L-精氨酸对内毒素血症肠道微循环的影响。
Crit Care Med. 2006 Jun;34(6):1752-7. doi: 10.1097/01.CCM.0000218812.73741.6C.
5
Endotoxin releases a substance from the aorta that dilates an isolated arteriole by up-regulating INOS.内毒素从主动脉释放出一种物质,该物质通过上调诱导型一氧化氮合酶(inos)使离体小动脉扩张。
J Surg Res. 2005 Aug;127(2):106-11. doi: 10.1016/j.jss.2005.03.025.
6
The effects of vasopressor and vasodilator on hemodynamic energy in terms of surplus hemodynamic energy.就剩余血流动力学能量而言,血管升压药和血管扩张剂对血流动力学能量的影响。
ASAIO J. 2008 Sep-Oct;54(5):534-7. doi: 10.1097/MAT.0b013e31818652fc.
7
Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock.去甲肾上腺素早期使用与延迟使用对复苏后内毒素休克的比较效果
Crit Care Med. 2007 Jul;35(7):1736-40. doi: 10.1097/01.CCM.0000269028.28521.08.
8
Vasopressor use in septic shock: an update.脓毒性休克中血管加压药的应用:最新进展
Curr Opin Anaesthesiol. 2008 Apr;21(2):141-7. doi: 10.1097/ACO.0b013e3282f46d20.
9
Vasopressin for the management of catecholamine-resistant anaphylactic shock.血管加压素用于治疗对儿茶酚胺抵抗的过敏性休克。
Singapore Med J. 2008 Sep;49(9):e225-8.
10
Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.多巴酚丁胺可代偿血管加压素在内毒素休克时对内脏区域产生的有害血流动力学和代谢效应。
Acta Anaesthesiol Scand. 2004 Sep;48(8):935-43. doi: 10.1111/j.0001-5172.2004.00435.x.

引用本文的文献

1
Is the Sympathetic System Detrimental in the Setting of Septic Shock, with Antihypertensive Agents as a Counterintuitive Approach? A Clinical Proposition.在感染性休克的情况下,交感神经系统是否有害,使用抗高血压药物作为一种有悖常理的方法是否可行?一项临床提议。
J Clin Med. 2021 Oct 1;10(19):4569. doi: 10.3390/jcm10194569.
2
Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock.硝酸甘油可逆转循环性休克患者外周灌注不良的临床表现。
Crit Care. 2014 Jun 19;18(3):R126. doi: 10.1186/cc13932.
3
HDFx: a novel biologic immunomodulator is therapeutically -effective in hemorrhagic and intestinal-ischemic shock: importance of microcirculatory-immunological interactions and their potential implications for the warfighter and disaster victims.HDFx:一种新型生物免疫调节剂在出血性和肠道缺血性休克中具有治疗效果:微循环免疫相互作用的重要性及其对战地人员和灾难受害者的潜在影响。
Int J Clin Exp Med. 2011;4(4):331-40. Epub 2011 Nov 9.
4
ENDOTOXIN SHOCK IN THE PRIMATE: TREATMENT WITH PHENOXYBENZAMINE.灵长类动物的内毒素休克:用酚苄明治疗
J Clin Invest. 1964 Feb;43(2):279-84. doi: 10.1172/JCI104912.
5
Small intestinal blood flow.小肠血流量。
Am J Dig Dis. 1963 Jul;8:587-613. doi: 10.1007/BF02239457.
6
Is there a place for proteinase inhibition? A review of the literature.蛋白酶抑制作用是否有其用武之地?文献综述
Postgrad Med J. 1969 Aug;45(526):571-3. doi: 10.1136/pgmj.45.526.571.

本文引用的文献

1
Experimental studies on therapy of circulatory failure produced by endotoxin.内毒素所致循环衰竭治疗的实验研究
J Lab Clin Med. 1961 May;57:683-93.
2
Physiological approach to successful treatment of endotoxin shock in the experimental animal.实验动物内毒素休克成功治疗的生理学方法。
AMA Arch Surg. 1959 Mar;78(3):464-71. doi: 10.1001/archsurg.1959.04320030108018.
3
The intestinal factor in irreversible endotoxin shock.不可逆性内毒素休克中的肠道因素。
Ann Surg. 1958 Oct;148(4):513-24; discussion 524-5. doi: 10.1097/00000658-195810000-00002.
4
The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. I. Certain similarities between the reactions in normal and endotoxin-tolerant rats.内毒素、创伤和出血所致休克的血管表现之间的关系。I. 正常大鼠和内毒素耐受大鼠反应的某些相似性。
J Exp Med. 1957 Sep 1;106(3):385-401. doi: 10.1084/jem.106.3.385.
5
Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms.革兰氏阴性微生物内毒素所致犬循环系统变化的研究。
J Clin Invest. 1956 Nov;35(11):1191-8. doi: 10.1172/JCI103373.
6
Hemodynamic effects of vasopressor agent (metaraminol) on hypotension in dogs produced by endotoxin.血管升压药(间羟胺)对犬内毒素所致低血压的血流动力学影响。
Proc Soc Exp Biol Med. 1956 Jul;92(3):610-2. doi: 10.3181/00379727-92-22559.
7
Canine intestinal and liver weight changes induced by E. coli endotoxin.大肠杆菌内毒素诱导的犬肠道和肝脏重量变化。
Proc Soc Exp Biol Med. 1956 Jul;92(3):602-5. doi: 10.3181/00379727-92-22557.
8
Hypotension (shock) in dogs produced by Escherichia coli endotoxin.大肠杆菌内毒素所致犬的低血压(休克)
Circ Res. 1956 Sep;4(5):546-56. doi: 10.1161/01.res.4.5.546.

内毒素休克的治疗——血管升压药与血管扩张剂治疗的困境

Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy.

作者信息

WEIL M H, SUDRANN R B, SHUBIN H

出版信息

Calif Med. 1962 Feb;96(2):86-8.

PMID:14005656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1574840/
Abstract

Hemodynamic studies have demonstrated that the fall of blood pressure in shock caused by endotoxin in dogs does not result primarily from dilatation or "vasomotor collapse." Indeed, vasoconstriction is increased and may be excessive. Progression of shock has recently been blamed on such excessive vasoconstriction. For this reason the use of sympathomimetic drugs as vasopressor agents has been challenged and sympatholytic or adrenolytic agents have been recommended. In the present study, vasopressor and vasodilator drugs were used for the treatment of shock in dogs caused by endotoxin. Vasodilator drugs, when used after the onset of shock, hastened a fatal outcome but vasopressor agents were not detrimental when used in moderate doses. The effectiveness of the vasopressor agent is not necessarily due to a primary vasoconstrictor action on arteries and arterioles, as previously assumed.

摘要

血流动力学研究表明,内毒素所致犬类休克时的血压下降并非主要源于血管扩张或“血管运动性虚脱”。事实上,血管收缩增强,甚至可能过度。近来,休克的进展被归咎于这种过度的血管收缩。因此,将拟交感神经药物用作血管升压药受到了质疑,有人推荐使用抗交感神经或抗肾上腺素能药物。在本研究中,血管升压药和血管扩张药被用于治疗内毒素所致犬类休克。休克发作后使用血管扩张药会加速致命结局,但中等剂量使用血管升压药并无危害。血管升压药的有效性不一定如先前所认为的那样,主要归因于对动脉和小动脉的原发性血管收缩作用。